Joran Hjelmesaeth
Overview
Explore the profile of Joran Hjelmesaeth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
171
Citations
2104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kushner R, Ryan D, Deanfield J, Kokkinos A, Cercato C, Wilding J, et al.
Obesity (Silver Spring)
. 2025 Feb;
33(3):452-462.
PMID: 39948761
Objective: The objective of this study was to assess safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo, beyond reduction in major adverse cardiovascular events, in patients with established cardiovascular...
2.
Bliddal H, Bays H, Czernichow S, Hemmingsson J, Hjelmesaeth J, Hoffmann Morville T, et al.
N Engl J Med
. 2024 Oct;
391(17):1573-1583.
PMID: 39476339
Background: Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in knee osteoarthritis among persons...
3.
Otterstad J, Munkhaugen J, Ruddox V, Edvardsen T, Hjelmesaeth J
Scand Cardiovasc J
. 2024 Aug;
58(1):2386984.
PMID: 39106197
To investigate whether normal body mass index (BMI) shortly after percutaneous coronary intervention (PCI) for myocardial infarction is associated with increased risk of long-term major cardiovascular events (MACE), and to...
4.
Wahlstrom A, Aydin O, Olsson L, Sjoland W, Henricsson M, Lundqvist A, et al.
EBioMedicine
. 2024 Aug;
106:105265.
PMID: 39096744
Background: Bariatric surgery is an effective treatment option for obesity and provides long-term weight loss and positive effects on metabolism, but the underlying mechanisms are poorly understood. Alterations in bile...
5.
Karlsson C, Johnson L, Greasley P, Retterstol K, Hedberg J, Hall M, et al.
JAMA Surg
. 2024 Jul;
159(9):971-980.
PMID: 38959017
Importance: Roux-en-Y gastric bypass (RYGB) is associated with reduced cardiovascular (CV) risk factors, morbidity, and mortality. Whether these effects are specifically induced by the surgical procedure or the weight loss...
6.
Kvitne K, Hjelmesaeth J, Hovd M, Sandbu R, Johnson L, Andersson S, et al.
Clin Pharmacol Ther
. 2024 May;
116(3):647-652.
PMID: 38771070
This article summarizes the lessons learned from the COCKTAIL study: an open, three-armed, single-center study including patients with obesity scheduled for treatment with Roux-en-Y gastric bypass (RYGB) or nonsurgical calorie...
7.
Kvitne K, Hovd M, Johnson L, Wegler C, Karlsson C, Artursson P, et al.
Clin Pharmacokinet
. 2023 Nov;
63(1):109-120.
PMID: 37993699
Background And Objective: Several drugs on the market are substrates for P-glycoprotein (P-gp), an efflux transporter highly expressed in barrier tissues such as the intestine. Body weight, weight loss, and...
8.
Hjelmesaeth J, Torheim L, Arnesen E
Tidsskr Nor Laegeforen
. 2023 Sep;
143(13).
PMID: 37753756
No abstract available.
9.
Hjelmesaeth J, Torheim L, Arnesen E
Tidsskr Nor Laegeforen
. 2023 Sep;
143(13).
PMID: 37753754
No abstract available.
10.
Handin N, Yuan D, Olander M, Wegler C, Karlsson C, Jansson-Lofmark R, et al.
Comput Struct Biotechnol J
. 2023 Sep;
21:4361-4369.
PMID: 37711184
Human liver tissue is composed of heterogeneous mixtures of different cell types and their cellular stoichiometry can provide information on hepatic physiology and disease progression. Deconvolution algorithms for the identification...